hotspot -WSS

hotspot

author：focus 2025-10-01 00:49:10 - browse：94

In a surprise move, the Food and Drug Administration has called for a meeting of outside advisers to discuss whether an Alzheimer’s drug from Eli Lilly should be approved, even as many outsiders expected the medicine to receive regulatory clearance this month.

The drug, donanemab, succeeded in its Phase 3 trial, resulting in a 35% slowing of Alzheimer’s disease progression versus placebo. But Lilly on Friday said that the FDA expects to call a meeting of an advisory committee to review the trial, saying that the agency had told the company “it wants to further understand topics related to evaluating the safety and efficacy of donanemab, including the safety results in donanemab-treated patients and the efficacy implications of the unique trial design” of the study.

A date for the meeting has not been set yet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Biotech startup Celsius cuts 75% of staff ahead of first trial start

WSS

Pig kidney works a record two months in donated body

Personalized medicine goes far beyond genetics

Long Covid needs a new name — and a new frame

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Acelyrin, a rare IPO success, stumbles in its first big test

Group behind ProMed defends move to subscription

Wikipedia

hotspot

hotspot

In Memoriam: Notable people who died in 2023

Biotech startup Celsius cuts 75% of staff ahead of first trial start

Psychedelics group wrestles with new pharma identity

FDA approves Sage Therapeutics’ rapid

Tori Bowie and the unacceptable rates of Black maternal death

FDA approves updated Covid vaccines

The high cost of giving birth even with insurance

When waiting feels immoral: Empathy in the emergency department

After affirmative action ruling, medical educators look to 'holistic review'

Food makers to regulators: Ultra

knowledge

Heart disease in astronauts blamed on cosmic radiation

Hospitals consider fixing cancer drug shortages on their own

IRA could hurt research into orphan drugs for rare diseases

Listen: Covid's latest surge, Alnylam at the FDA, & the end of an era

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

CDC recommends RSV monoclonal antibody for infants

focus

focus

Wikipedia

knowledge